Published in Lab Business Week, September 5th, 2004
The article entitled "A Synthetic 15mer Peptide (PCK3145) Derived From Prostate Secretory Protein (PSP-94) Can Reduce Tumor Growth, Experimental Skeletal Metastases And Malignancy Associated Hypercalcemia" demonstrates the efficacy of PCK3145 in reducing tumor volume and delaying the development of skeletal metastases in a preclinical Mat Ly Lu model of prostate cancer.
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Lab Business Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.